Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | MMP1 | P03956 | 2/20 | 0.42 |
| ▸ | MMP2 | P08253 | 2/20 | 0.42 |
| ▸ | MMP9 | P14780 | 2/20 | 0.42 |
| ▸ | MMP8 | P22894 | 2/20 | 0.42 |
| ▸ | MMP13 | P45452 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | F2 | P00734 | 3/20 | 0.38 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.38 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.38 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL715981 | 0.97 | CA2 (0.44) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL713729 | 0.97 | CA2 (0.44) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL716291 | 0.97 | CA2 (0.44) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL714854 | 0.97 | CA2 (0.44) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL716687 | 0.97 | CA2 (0.44) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL2497076 | 0.97 | ALDH1A1 (0.41) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL217909 | 0.97 | ALDH1A1 (0.41) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL714652 | 0.94 | ALDH1A1 (0.43) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL5066773 | 0.92 | CA2 (0.54) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL1462867 | 0.92 | CA2 (0.54) | CA2CA1MMP1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2610308-B1 | USE OF POLYCARBOSILANE AS DISPERSANT FOR FLUOROPOLYMERS IN POLYCARBONATE RESINS | MITSUBISHI ENG PLASTICS CORP (JP) | 2020-07-15 | — | — | EP | disclosed |
| EP-2743314-B1 | POLYCARBONATE RESIN COMPOSITION AND MOLDED OBJECT THEREOF | MITSUBISHI ENG PLASTICS CORP (JP) | 2020-02-26 | — | — | EP | disclosed |
| EP-2520617-B1 | POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE | MITSUBISHI ENG PLASTICS CORP (JP) | 2015-03-25 | — | — | EP | disclosed |
| US-8865342-B2 | Polycarbonate resin composition and molded article | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2014-10-21 | — | — | US | disclosed |
| US-8802758-B2 | Polycarbonate resin composition and formed product thereof | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2014-08-12 | — | — | US | disclosed |
| US-8785528-B2 | Polycarbonate resin composition and formed product thereof | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2014-07-22 | — | — | US | disclosed |
| US-8772385-B2 | Polycarbonate resin composition and formed product thereof | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2014-07-08 | — | — | US | disclosed |
| US-8729180-B2 | Polycarbonate resin composition and formed product thereof | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2014-05-20 | — | — | US | disclosed |
| US-8710129-B2 | Polycarbonate resin composition and formed product thereof | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2014-04-29 | — | — | US | disclosed |
| EP-2395052-B1 | POLYCARBONATE RESIN COMPOSITION AND MOLDED OBJECT THEREOF | MITSUBISHI ENG PLASTICS CORP (JP) | 2014-03-12 | — | — | EP | disclosed |
| US-20130324650-A1 | POLYCARBONATE RESIN COMPOSITION AND FORMED PRODUCT THEREOF | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2013-12-05 | — | — | US | disclosed |
| US-8575263-B2 | Polycarbonate resin composition and formed product thereof | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2013-11-05 | — | — | US | disclosed |
| US-20130253109-A1 | POLYCARBONATE RESIN COMPOSITION AND FORMED PRODUCT THEREOF | MITSUBISHI ENG PLASTICS CORP (JP) | 2013-09-26 | — | — | US | disclosed |
| US-20130210980-A1 | POLYCARBONATE RESIN COMPOSITION AND FORMED PRODUCT THEREOF | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2013-08-15 | — | — | US | disclosed |
| US-20130210981-A1 | POLYCARBONATE RESIN COMPOSITION AND FORMED PRODUCT THEREOF | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2013-08-15 | — | — | US | disclosed |
| US-20130203912-A1 | POLYCARBONATE RESIN COMPOSITION AND FORMED PRODUCT THEREOF | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2013-08-08 | — | — | US | disclosed |
| US-8492476-B2 | Polycarbonate resin composition and formed product thereof | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2013-07-23 | — | — | US | disclosed |
| US-20120301766-A1 | POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2012-11-29 | — | — | US | disclosed |
| EP-2520617-A1 | POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE | Mitsubishi Engineering-Plastics Corporation (JP) | 2012-11-07 | — | — | EP | disclosed |
| US-20110245388-A1 | POLYCARBONATE RESIN COMPOSITION AND FORMED PRODUCT THEREOF | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2011-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110245388-A1 | POLYCARBONATE RESIN COMPOSITION AND FORMED PRODUCT THEREOF | PTCD3, PSMC2, COPE | CA2 1319/4885CA1 1051/4885MMP1 3937/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.